Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 132,663 | reported | 01 Apr 2019 | tx 11+168,058−80,258 |
| Generate Biomedicines, Inc. | 29,561 | reported | 26 Feb 2026 | tx 1+29,561 |
| Cyclerion Therapeutics, Inc. | 20,000 | reported | 14 Jun 2022 | tx 8+83,900 |
| Syros Pharmaceuticals, Inc. | 16,000 | reported | 05 Jun 2024 | tx 14+158,500 |
| MOMENTA PHARMACEUTICALS INC | 14,500 | reported | 23 Jun 2016 | tx 15+212,050−67,800 |
| ALNYLAM PHARMACEUTICALS, INC. | 3,454 | reported | 18 May 2023 | tx 31+244,242−160,136 |
| Forma Therapeutics Holdings, Inc., | 0 | reported | 14 Oct 2022 | tx 17+92,440−202,413 |
| MILLENNIUM PHARMACEUTICALS INC | 0 | reported | 14 May 2008 | tx 44+287,495−906,495 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | Generate Biomedicines, Inc. | 29,561 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 3,454 | 0.00 USD | deriv |
| 23 Feb 2023 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 136 | 0.00 USD | |
| 23 Feb 2023 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 136 | 0.00 USD | deriv |
| 14 Oct 2022 | TENDER | Forma Therapeutics Holdings, Inc., | 52,532 | — | |
| 14 Oct 2022 | TENDER | Forma Therapeutics Holdings, Inc., | 7,250 | — | |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 6,750 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 8,375 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 17,533 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 28,053 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 14,026 | — | deriv |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 8,000 | 0.00 USD | |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Cyclerion Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 4,500 | 0.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 6,750 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 18 May 2022 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 5,153 | 0.00 USD | deriv |
| 23 Feb 2022 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 136 | 0.00 USD | deriv |
| 15 Jul 2021 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4,032 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Cyclerion Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 23 Jun 2020.